LPL Financial
CPRX

LPL Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

LPL Financial’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.6M Sell
50,998
-56,588
-53% -$1.67M ﹤0.01% 3991
2026
Q1 		$2.66M Buy
107,586
+41,536
+63% +$990K ﹤0.01% 3234
2025
Q4 		$1.54M Buy
66,050
+1,568
+2% +$34.9K ﹤0.01% 3636
2025
Q3 		$1.27M Sell
64,482
-36,967
-36% -$760K ﹤0.01% 3768
2025
Q2 		$2.2M Buy
101,449
+27,220
+37% +$643K ﹤0.01% 3034
2025
Q1 		$1.8M Buy
74,229
+16,246
+28% +$366K ﹤0.01% 3041
2024
Q4 		$1.21M Buy
57,983
+15,961
+38% +$343K ﹤0.01% 3335
2024
Q3 		$835K Buy
42,022
+2,558
+6% +$47.4K ﹤0.01% 3557
2024
Q2 		$611K Sell
39,464
-22,073
-36% -$344K ﹤0.01% 3692
2024
Q1 		$981K Sell
61,537
-8,986
-13% -$135K ﹤0.01% 3197
2023
Q4 		$1.19M Sell
70,523
-15,649
-18% -$214K ﹤0.01% 2898
2023
Q3 		$1.01M Buy
86,172
+52,294
+154% +$700K ﹤0.01% 2881
2023
Q2 		$455K Sell
33,878
-33,334
-50% -$480K ﹤0.01% 3520
2023
Q1 		$1.11M Buy
67,212
+14,646
+28% +$242K ﹤0.01% 2673
2022
Q4 		$978K Buy
52,566
+28,159
+115% +$434K ﹤0.01% 2665
2022
Q3 		$313K Buy
24,407
+1,431
+6% +$17K ﹤0.01% 3542
2022
Q2 		$161K Buy
22,976
+4,210
+22% +$30.9K ﹤0.01% 4010
2022
Q1 		$156K Buy
18,766
+3,128
+20% +$22.1K ﹤0.01% 3887
2021
Q4 		$106K Sell
15,638
-4,435
-22% -$29.2K ﹤0.01% 4127
2021
Q3 		$106K Buy
+20,073
New +$110K ﹤0.01% 4128
2020
Q4 		– Sell
-10,000
Closed -$30K – 3816
2020
Q3 		$30K Buy
+10,000
New +$39.1K ﹤0.01% 3476

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial's CPRX Position: Q2 2026 in Review

LPL Financial reduced its Catalyst Pharmaceutical (CPRX) stake by 53% in Q2 2026, selling an estimated $1.67M and leaving 50,998 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3991.

LPL Financial first reported a position in CPRX in Q3 2020 and has held it in 21 quarters since. The position peaked at $2.66M in Q1 2026. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • LPL Financial held 50,998 shares of Catalyst Pharmaceutical worth $1.6M as of Q2 2026.
  • LPL Financial sold 56,588 Catalyst Pharmaceutical shares in Q2 2026, an estimated $1.67M.
  • Catalyst Pharmaceutical made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3991 holding.
  • LPL Financial first reported a position in Catalyst Pharmaceutical in Q3 2020 and has held it in 21 quarters since.
  • LPL Financial's Catalyst Pharmaceutical position peaked at $2.66M in Q1 2026.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.